Edwin has spent over 20 years bringing new life science technologies to market, the last 10 of these focused on solving the challenges of cell therapy manufacturing.  He established TTP’s cell and gene team which developed over 10 cell therapy automation systems, including systems that are now in routine use for commercial therapy manufacture. Seeing the challenge of scale remained unaddressed, Edwin co-founded Cellular Origins where he is passionate about enabling patient access to cell therapies through scalable, cost-effective and space efficient manufacturing enabled by the Constellation™ automated cell therapy manufacturing platform.  He holds a Master’s degree in Engineering and a PhD in robotic vehicles from the University of Cambridge,